Gamida Cell Ltd. (GMDA) Misses Q2 EPS by 2c
Get Alerts GMDA Hot Sheet
Join SI Premium – FREE
Gamida Cell Ltd. (NASDAQ: GMDA) reported Q2 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).
Finished second quarter of 2022 with $55.1 million in cash; sufficient funding for the company’s operations into mid-2023, excluding the cost of commercializing omidubicel.
For earnings history and earnings-related data on Gamida Cell Ltd. (GMDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Gamida Cell (GMDA) Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
- Walgreens Boots Alliance (WBA) tops Q2 expectations, narrows full-year profit forecast
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!